Annual influenza vaccination does not prevent natural immunity

November 14, 2017
Picture of researcher working with vaccines. Credit: University of Bergen

Earlier studies have suggested that having repeated annual influenza vaccination can prevent natural immunity to the virus, and potentially increase the susceptibility to influenza illness in the event of a pandemic, or when the vaccine does not match the virus circulating in the population.

But now, researchers at the Influenza Center in Bergen report that annual influenza vaccination does not increase susceptibility to influenza infection in years of mismatch.

"These findings are important because they show that it is only positive to have annual influenza vaccination, and it supports continuing the policy of repeated annual vaccination," says Professor Rebecca Cox, Head of the Influenza Centre.

A better first line defence

Researchers at the Influenza Centre in Bergen have followed 250 over a period of five years. They were vaccinated in 2009, and had annual vaccination in all subsequent seasons or no further vaccination between 2010 and 2013. The researchers collected 3000 blood samples.

The results showed that health care workers who had annual vaccination and those who did not get vaccinated annually had the same second-line defence, but those who had gotten annual vaccines had a better first-line defence. The group that had annual vaccination was not prevented from developing .

Important for the risk groups

Almost 1.5 million people in Norway have an increased risk of influenza complications. The influenza vaccine is annually updated to adapt to rapid virus evolution. It is the only vaccine that is recommended on annual basis.

"For people in the risk groups, could lead to pneumonia and exacerbation of chronic underlying diseases. Influenza can result in hospitalisation, in the elderly this may lead to institutionalisation, and in the worst case death. That is why it is so important that we can continue to recommend annual vaccination, especially now we know that it does not prevent natural infection," says Cox.

"Influenza vaccines have been in use for over 50 years, but there are very few studies that have been able to follow the same people for a long period of time, particularly such a well-documented group of vaccinated people."

Explore further: More than 78 percent of health care personnel receive flu shot

More information: Mai-Chi Trieu et al, Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination, Journal of Infectious Diseases (2016). DOI: 10.1093/infdis/jiw619

Related Stories

More than 78 percent of health care personnel receive flu shot

September 29, 2017
(HealthDay)—More than 78 percent of health care personnel (HCP) and 53.6 percent of pregnant women received influenza vaccination during the 2016-2017 influenza season, according to two studies published in the Sept. 29 ...

Patients with flu-associated pneumonia less likely to have received flu vaccine

October 5, 2015
Among children and adults hospitalized with community-acquired pneumonia, those with influenza-associated pneumonia, compared with those with pneumonia not associated with influenza, had lower odds of having received an influenza ...

Study finds flu vaccine helps reduce hospitalizations due to influenza pneumonia

October 13, 2015
More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal ...

Flu vaccine uptake slightly higher in provinces that allow vaccination by pharmacists

August 8, 2016
People who live in provinces with policies that allow pharmacists to administer influenza vaccines are more likely to be vaccinated, according to a new study in CMAJ (Canadian Medical Association Journal)

Low influenza vaccination rates among nursing home employees put residents at risk, study finds

January 27, 2015
Influenza is associated with as many as 7,300 deaths annually in nursing home residents, but the vaccination rate for nursing home staff is only 54 percent, according to a study in the February issue of the American Journal ...

Season influenza vaccination of children predicted to be highly cost-effective in Thailand

May 26, 2015
Seasonal influenza vaccination of children is likely to represent good short-term value for money in Thailand, according to a study published this week in PLOS Medicine. The study, led by Aronrag Meeyai of the Health Intervention ...

Recommended for you

Study explores whole-body immunity

November 21, 2017
Over the next few months, millions of people will receive vaccinations in the hope of staving off the flu—and the fever, pain, and congestion that come with it.

Drug could cut transplant rejection

November 21, 2017
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London ...

Atopic eczema—one size does not fit all

November 21, 2017
Researchers from the UK and Netherlands have identified five distinct subgroups of eczema, a finding that helps explain how the condition can affect people at different stages of their lives.

Breast milk found to protect against food allergy

November 20, 2017
Eating allergenic foods during pregnancy can protect your child from food allergies, especially if you breastfeed, suggests new research from Boston Children's Hospital. The study, published online today in the Journal of ...

Zika-related nerve damage caused by immune response to the virus

November 20, 2017
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients ...

How a poorly explored immune cell may impact cancer immunity and immunotherapy

November 17, 2017
The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.